A New Approach For Faster, Safer Healing
THE PROBLEM
Sepsis Is A Global Emergency
Sepsis is a critical, life-threatening condition that affects millions every year and is a leading cause of death in hospital intensive care units.
Despite early intervention with antibiotics and supportive care, many patients deteriorate rapidly due to persistent bloodstream infections, drug-resistance, and an overwhelming inflammatory response. Current treatments are slow to act and rely on the body’s ability to respond—something many patients in critical condition cannot do fast enough.
OUR SOLUTION
Taking On Sepsis At Its Source
CycloPE® is a novel blood purification device designed to selectively and rapidly remove Gram-positive and Gram-negative bacteria directly from the bloodstream.
- Blood is circulated through a helical channel functionalized with high-affinity binding ligands.
- The device captures pathogens while preserving essential blood components.
- Treatment is performed using existing ICU equipment in a standard extracorporeal setup.
THE RESULT
Faster infection control, improved patient stabilization, and a potential reduction in downstream organ damage.
Image courtesy of Texas Medical Center
A UNIQUE PRODUCT
Why CycloPE® is Different
Breakthrough technology when timing matters most.
CycloPE® is an advanced blood purification therapy that treats sepsis by directly removing bacteria from the bloodstream. As blood passes through the device, harmful pathogens are captured while essential blood components remain intact and unaffected. Designed to integrate seamlessly with standard ICU systems, CycloPE® enables rapid bacterial clearance and supports faster patient recovery.
Direct Pathogen Removal
CycloPE® treats the source of the infection, bacteria.
Rapid Response
The device can be used prior to pathogen identification, getting patients started on a therapy when time matters.
Broad Spectrum
CycloPE® is bacteria agnostic, removing drug-susceptible and drug resistance bacteria.
Seamless Integration
The device has been designed to fit into existing hospital workflow and infrastructure.
Targeted Therapy
CycloPE® targets and removes bacteria without changing the patients’ blood profile.
Clinical Data
Positive clinical data has shown safety, efficacy, and improvement in clinical markers tied to sepsis patient outcomes.
